Cargando…
Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a threat for the global TB epidemic control. Despite existing evidence that individualized treatment of MDR-TB is superior to standardized regimens, the latter are recommended in Brazil, mainly because drug-susceptibility tests (DST) are often...
Autores principales: | Bastos, Mayara Lisboa, Cosme, Lorrayne Beliqui, Fregona, Geisa, do Prado, Thiago Nascimento, Bertolde, Adelmo Inácio, Zandonade, Eliana, Sanchez, Mauro N., Dalcolmo, Margareth Pretti, Kritski, Afrânio, Trajman, Anete, Maciel, Ethel Leonor Noia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686842/ https://www.ncbi.nlm.nih.gov/pubmed/29137626 http://dx.doi.org/10.1186/s12879-017-2810-1 |
Ejemplares similares
-
Risk factors associated with multidrug-resistant tuberculosis in Espírito Santo, Brazil
por: Fregona, Geisa, et al.
Publicado: (2017) -
Reflections upon the article “Evaluation of the impact that the changes in tuberculosis treatment implemented in Brazil in 2009 have had on disease control in the country”
por: Maciel, Ethel Leonor, et al.
Publicado: (2018) -
Comparison of Interferon-γ Release Assay to Two Cut-Off Points of Tuberculin Skin Test to Detect Latent Mycobacterium tuberculosis Infection in Primary Health Care Workers
por: de Souza, Fernanda Mattos, et al.
Publicado: (2014) -
Variação na detecção da síndrome congênita do Zika em função de alterações em protocolos
por: Mocelin, Helaine Jacinta Salvador, et al.
Publicado: (2019) -
Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil
por: Bhering, Marcela, et al.
Publicado: (2022)